Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay (2021)
Attributed to:
Defining the role of src family kinases in cytomegalovirus reactivation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2021.03.010
PubMed Identifier: 33753152
Publication URI: http://europepmc.org/abstract/MED/33753152
Type: Journal Article/Review
Parent Publication: Journal of Infection
Issue: 5
ISSN: 0163-4453